What Is the Future Outlook for Remission in Pediatric Severe Asthma?

Listen to Len Bacharier, MD and Sharon Dell, MD, FRCPC, as they highlight the natural course of pediatric asthma progression over time, discuss differences between spontaneous remission and on-treatment clinical remission, and provide a commentary on what we have learned from the recent developments around remission in adults and how it could relate more specifically to pediatric populations.   ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. Disclaimer:  This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits Speaker disclosures: Len Bacharier, MD has served as an advisor, consultant, speaker, and/or investigator for AstraZeneca, Avillion, DBV Technologies, Genentech/Novartis, GlaxoSmithKline, Kinaset, OM Pharma, Recludix, Regeneron Pharmaceuticals, Inc., Sanofi, Vertex; has provided grant and/or research support for NIH (NHLBI, NIAID), Regeneron Pharmaceuticals, Inc., Sanofi; and has provided other support for DBV Technologies Sharon Dell, MD has served as an advisor, consultant, and/or speaker for  AstraZeneca, Novartis, Regeneron Pharmaceuticals, Sanofi; and has provided grant and/or research support for Boehringer Ingelheim, Merck, Parion Sciences, Sanofi, Vertex Pharmaceuticals © 2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2305935 v1.0 12/2023 MAT-US-2305475 v1.0 - P Expiration Date: 12/22/2025